Albert  DaCosta net worth and biography

Albert DaCosta Biography and Net Worth

Chairman, CEO, Co-Founder of Paragon 28

Albert DaCosta is a veteran in the Foot & Ankle marketplace with over 14 years experience and a passion directed toward discovering the optimal way to treat patients with lower extremity ailments. His obsession drives him to surround himself with like-minded people and build teams that work tirelessly to advance the science of our segment. Prior to establishing P28, Albert was a distributor for both Pioneer Surgical and Biomet Sports Medicine with responsibility spanning 12 states. Mr. DaCosta served as the Director of Biologics & Extremities for Wright Medical. He served as President of Non-Invasive Solutions, a company focused on lithotripsy for plantar fasciitis and lateral epicondylitis in 2005 as well as President & Founder of Body Beautiful Laser Centers in South Florida in 2006. Albert earned a B.S. in Chemical Engineering from the University of Florida with a minor in Business.

What is Albert DaCosta's net worth?

The estimated net worth of Albert DaCosta is at least $69.81 million as of March 15th, 2024. Mr. DaCosta owns 5,339,110 shares of Paragon 28 stock worth more than $69,808,863 as of April 4th. This net worth approximation does not reflect any other assets that Mr. DaCosta may own. Additionally, Mr. DaCosta receives an annual salary of $1,400,000.00 as Chairman, CEO, Co-Founder at Paragon 28. Learn More about Albert DaCosta's net worth.

How old is Albert DaCosta?

Mr. DaCosta is currently 50 years old. There are 5 older executives and no younger executives at Paragon 28. Learn More on Albert DaCosta's age.

What is Albert DaCosta's salary?

As the Chairman, CEO, Co-Founder of Paragon 28, Inc., Mr. DaCosta earns $1,400,000.00 per year. Learn More on Albert DaCosta's salary.

How do I contact Albert DaCosta?

The corporate mailing address for Mr. DaCosta and other Paragon 28 executives is , , . Paragon 28 can also be reached via phone at 720-912-1332 and via email at ir@paragon28.com. Learn More on Albert DaCosta's contact information.

Has Albert DaCosta been buying or selling shares of Paragon 28?

Albert DaCosta has not been actively trading shares of Paragon 28 during the past quarter. Most recently, on Friday, March 15th, Albert Dacosta bought 28,000 shares of Paragon 28 stock. The stock was acquired at an average cost of $9.12 per share, with a total value of $255,360.00. Following the completion of the transaction, the insider now directly owns 5,339,110 shares of the company's stock, valued at $48,692,683.20. Learn More on Albert DaCosta's trading history.

Who are Paragon 28's active insiders?

Paragon 28's insider roster includes Albert DaCosta (Co-Founder), Albert DaCosta (Chairman, CEO, Co-Founder), Stephen Deitsch (CFO & Principal Fin. Officer ), and Kristina Wright (Director). Learn More on Paragon 28's active insiders.

Are insiders buying or selling shares of Paragon 28?

In the last twelve months, insiders at the sold shares 10 times. They sold a total of 2,128,898 shares worth more than $26,945,485.06. The most recent insider tranaction occured on March, 13th when Major Shareholder Mvm Partners, Llc sold 1,044,295 shares worth more than $13,617,606.80. Insiders at Paragon 28 own 15.3% of the company. Learn More about insider trades at Paragon 28.

Information on this page was last updated on 3/13/2025.

Albert DaCosta Insider Trading History at Paragon 28

See Full Table

Albert DaCosta Buying and Selling Activity at Paragon 28

This chart shows Albert Dacosta's buying and selling at Paragon 28 by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$5M$0$5MTotal Insider BuyingTotal Insider Selling

Paragon 28 Company Overview

Paragon 28 logo
Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
Read More

Today's Range

Now: $13.08
Low: $13.03
High: $13.09

50 Day Range

MA: $12.95
Low: $11.63
High: $13.09

2 Week Range

Now: $13.08
Low: $4.65
High: $13.13

Volume

753,991 shs

Average Volume

895,187 shs

Market Capitalization

$1.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54